Assembly Biosciences (ASMB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,122 | -40,177 | -61,228 | -93,092 | -129,855 |
| Depreciation Amortization | -2,217 | -3,529 | -1,135 | 653 | 42,690 |
| Income taxes - deferred | N/A | N/A | N/A | N/A | -2,531 |
| Accounts receivable | -974 | 43 | 901 | -608 | 894 |
| Other Working Capital | -38,279 | -11,948 | 76,341 | -2,122 | -11,401 |
| Other Operating Activity | 6,499 | 4,494 | 7,864 | 10,706 | 6,807 |
| Operating Cash Flow | $-41,093 | $-51,117 | $22,743 | $-84,463 | $-93,396 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -66 | -28 | -231 | -102 | -2,239 |
| Purchase Of Investment | -229,834 | -90,501 | -133,922 | -27,583 | -160,446 |
| Sale Of Investment | 116,432 | 130,700 | 65,015 | 116,825 | 187,700 |
| Other Investing Activity | 0 | 0 | 0 | 1,500 | 1,500 |
| Investing Cash Flow | $-113,468 | $40,171 | $-69,138 | $90,640 | $26,515 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 169,157 | 29,449 | 13,818 | 614 | 53,064 |
| Other Financing Activity | 5,510 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $174,667 | $29,449 | $13,818 | $614 | $53,064 |
| Beginning Cash Position | 38,344 | 19,841 | 52,418 | 45,627 | 59,444 |
| End Cash Position | 58,450 | 38,344 | 19,841 | 52,418 | 45,627 |
| Net Cash Flow | $20,106 | $18,503 | $-32,577 | $6,791 | $-13,817 |
| Free Cash Flow | |||||
| Operating Cash Flow | -41,093 | -51,117 | 22,743 | -84,463 | -93,396 |
| Capital Expenditure | -66 | -28 | -255 | -102 | -3,096 |
| Free Cash Flow | -41,159 | -51,145 | 22,488 | -84,565 | -96,492 |